HCV treatment lowers cardiovascular event risk

And direct-acting antivirals come up trumps

Treating a person with chronic hepatitis C (HCV) can nearly halve their risk of having a cardiovascular event such as myocardial infarct or stroke, a large US study shows.

In the retrospective study, more than 17,000 veterans treated for HCV were compared with matched controls who had the disease but were not treated for it.